Varian Medical Systems, Inc. (NYSE:VAR) is set to announce its earnings results after the market closes on Tuesday, October 24th. Analysts expect the company to announce earnings of $1.19 per share for the quarter. Varian Medical Systems has set its Q4 guidance at $1.15-$1.23 EPS.

Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings data on Wednesday, July 26th. The medical equipment provider reported $1.04 EPS for the quarter, beating the Zacks’ consensus estimate of $0.95 by $0.09. Varian Medical Systems had a net margin of 9.50% and a return on equity of 24.70%. The firm had revenue of $662.40 million for the quarter, compared to the consensus estimate of $663.86 million. During the same period in the previous year, the firm posted $1.00 earnings per share. The firm’s revenue was up 3.0% on a year-over-year basis. On average, analysts expect Varian Medical Systems to post $3.93 EPS for the current fiscal year and $4.44 EPS for the next fiscal year.

Varian Medical Systems, Inc. (NYSE VAR) opened at 102.83 on Tuesday. The company’s 50-day moving average is $103.97 and its 200-day moving average is $99.49. The stock has a market capitalization of $9.44 billion, a P/E ratio of 33.85 and a beta of 0.57. Varian Medical Systems, Inc. has a 12 month low of $75.20 and a 12 month high of $107.87.

COPYRIGHT VIOLATION WARNING: “Varian Medical Systems, Inc. (VAR) Scheduled to Post Quarterly Earnings on Tuesday” was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at https://www.americanbankingnews.com/2017/10/17/varian-medical-systems-inc-var-scheduled-to-post-quarterly-earnings-on-tuesday.html.

Several brokerages have commented on VAR. BidaskClub upgraded shares of Varian Medical Systems from a “sell” rating to a “hold” rating in a report on Saturday, August 12th. Robert W. Baird restated a “neutral” rating and set a $99.00 target price (up from $89.00) on shares of Varian Medical Systems in a report on Friday, July 14th. Zacks Investment Research downgraded shares of Varian Medical Systems from a “buy” rating to a “hold” rating in a report on Thursday, July 13th. BTIG Research downgraded shares of Varian Medical Systems from a “buy” rating to a “neutral” rating in a report on Thursday, September 7th. They noted that the move was a valuation call. Finally, Royal Bank Of Canada restated a “hold” rating and set a $100.00 target price on shares of Varian Medical Systems in a report on Friday, September 1st. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $94.94.

In other news, EVP Kolleen T. Kennedy sold 931 shares of the firm’s stock in a transaction that occurred on Thursday, August 31st. The shares were sold at an average price of $105.00, for a total transaction of $97,755.00. Following the completion of the transaction, the executive vice president now directly owns 27,531 shares of the company’s stock, valued at approximately $2,890,755. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Dow R. Wilson sold 15,059 shares of the firm’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $96.48, for a total transaction of $1,452,892.32. Following the transaction, the insider now directly owns 81,835 shares of the company’s stock, valued at $7,895,440.80. The disclosure for this sale can be found here. Insiders have sold a total of 55,956 shares of company stock valued at $5,692,553 over the last ninety days. Company insiders own 0.91% of the company’s stock.

Varian Medical Systems Company Profile

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Earnings History for Varian Medical Systems (NYSE:VAR)

Receive News & Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.